As New Zealand’s first specialised deep healthtech venture capital fund, our purpose is to grow the New Zealand healthtech sector by: * Investing in the growth and acceleration of innovative and globally competitive healthtech companies in New Zealand; and *Achieving good returns, societal benefits and global health impact for investors from New Zealand’s world class innovative ideas, technologies and scientific discoveries in healthcare. CaraMed Capital aims to provide access to the capital, connections, capability and global experience that New Zealand’s healthtech ventures need to thrive.